Bookmark and Share

Last Minute: "Doctors demand 30% pay rise as some medics say they may have to go on strike - Sky News" Tue, 28 Jun 2022 02:11:40 GMT    "The party's almost over for Sturgeon's Nats, and they know it - The Telegraph" Mon, 27 Jun 2022 18:05:00 GMT    "Birmingham explosion: Woman dies following blast at a home in Kingstanding - ITV News" Mon, 27 Jun 2022 16:59:35 GMT    "Russia-Ukraine war: rescuers dig for survivors of Kremenchuk shopping centre attack amid global outrage ? live - The Guardian" Tue, 28 Jun 2022 04:50:00 GMT    "Boris Johnson wins Commons vote on bill to rip up N Ireland protocol - Financial Times" Mon, 27 Jun 2022 22:13:02 GMT    "British Army chief: Ukraine is our '1937 moment' - The Telegraph" Mon, 27 Jun 2022 22:23:00 GMT   "'These deaths are on Biden': Republican Texas governor blames president after at least 46 people found dead in lorry - Sky News" Tue, 28 Jun 2022 06:22:30 GMT    "Police name woman, 35, ?murdered by stranger? in Ilford as man arrested - The Independent" Mon, 27 Jun 2022 19:59:26 GMT    "Family of girl, 4, killed by speeding driver welcome law change - BBC" Tue, 28 Jun 2022 05:26:57 GMT    "Concerns for missing East Yorkshire teenager Faith who has not been seen for a week - Hull Live" Mon, 27 Jun 2022 17:30:49 GMT      For more news, click here.

Remember me? 

PS: The quotes after 2011-02-25 are still temporary and may have for that reason the Open values wrong until furter updates...
Change to BAYER SCHERING PH Static Chart

Without price
BAYER SCHERING PH - [Ticker: SCH.F]Chart BAYER SCHERING PH  News BAYER SCHERING PH  Download Historical Prices for Metastock BAYER SCHERING PH and Others  Technical Analysis BAYER SCHERING PH  
Last Trade0.00Last Trade Time - 00:00:00
VariationN/A (N/A)Open0.00
Volume0Average Volume (3m)0
YieldBid / AskN/A
Former Close0.0052 Week Range[0.00 - 0.00]
Ex-Dividend DateDividend Payment
Market Capitalization0 1 Year Price-Target0.00
Note: The data may have some minutes of delay.

 News about BAYER SCHERING PH [SCH.F]:   (ordered by relevance)
Alpine Immune Sciences Appoints Andrew S. Sandler, M.D. as Chief Medical Officer  Business Wire Legendary Bayer is Reinventing its Story with Cell and Gene Therapy  BioSpace Bayer plans to stay the course amid investor pressure to split up, CEO says  FiercePharma Bayer poaches GlaxoSmithKline exec to lead expanding oncology business?including a blockbuster hopeful  FiercePharma New meds to drive growth of Bayer's Pharma business in Asia Pacific area  BusinessMirror With Bayer's new launches in infancy, Eylea and Xarelto still rule its pharma business?but for how long?  FiercePharma Bayer CEO Baumann faces revolt from investor Temasek Holdings: report  FiercePharma Merck counts 80-plus possible oncology drug approvals by 2028  FiercePharma JPM22, Day 1: Bayer strikes a Mammoth deal, no Sunday buyouts, Pfizer delves deeper in gene editing and more  FierceBiotech Bayer's pharma business in Asia Pacific drives growth in 2021; More innovative medicines to be launched Body plethysmographs of 2 manufacturers | COPD  Dove Medical Press Bayer nabs yet another oncology leader from GSK to bolster cancer efforts  FierceBiotech JPM 2022: Bayer taps CRISPR science from Doudna's lab in $1B biobucks Mammoth gene therapy deal  FierceBiotech Bayer pulls plug on $670M CAR-T cell therapy pact with Atara in wake of patient death  FierceBiotech ESC 2021: Bayer's Kerendia touts outcomes data as it looks to complement J&J, AZ drugs  FiercePharma Bayer's Farxiga rival Kerendia scores long-awaited kidney and heart disease nod for Type 2 diabetes patients  FiercePharma The top 20 pharma companies by 2021 revenue  FiercePharma 'The kidney medicine': Bayer touts Kerendia's blockbuster potential as its pharma group swings back to growth  FiercePharma Bayer's new CKD treatment Kerendia approved in EU  The Pharma Letter
For more news about BAYER SCHERING PH click here:

Search the Internet:

Website Width:
Bookmark and Share

 Background image:

Copyright@2010-2022 -, all rights reserved.
Investment Forum Stock Quotes Investment News Investment Chat Disclaimer Webmaster Resources